Close

Add to pipeline

Save Close
You are viewing a limited version of this profile. To access i3's full capabilities.
Bioceres
Save
Company logo (jpg or png)
Parent company
Edit alternate names

Short description

Developer of agricultural biotech solutions to engender drought resistance and cold hardiness in crops

Founded in 2001
Founded in

Company type Acquired Public (BIOX)
Company type

Industry Group agriculture & food

Sector crop inputs

TRL Range 9
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Argentina Santa Fe, Argentina
Address
City
State
Zip
Country

Parent Companies

Website

Updated by Jonathan Koch at on 01/25/2018

Edited by Cleantech Group on 04/01/2025

Traction
  • 1 M&A items
tags
Similar companies
Customers
Save
Add Customer
Date Company
Partnerships
Save
Add Partnership
Date Partner Type
09/16/2022
Syngenta Syngenta
Syngenta Seedcare becomes commercialization partner for Bioceres seed treatment
View source    
Confirmed by Syngenta
Channel Partner
Delete
Investment Rounds
Save

IPO INFORMATION

Date

03/19/2019

IPO status

Listed

IPO Type

SPAC

Amount

$100M

Initial shares

Ticker symbol

BIOX

Exchange listed

NYSE

Prospectus URL

Prospectus

Source URL

Source

Description

Bioceres to List on NYSE Raising $100m+ in Reverse IPO. The company is set to list on the New York Stock Exchange (NYSE) early next year through a reverse listing. The company will acquire Union Acquisition Corp. (NYSE: LTN) ("UAC"), a special purpose acquisition company. The deal will see Bioceres’ core agriculture business valued at around $450 million, according to a press release. it later announced in November 2018 that it would be acquired by SPAC Union Acquisition. The merger was completed on Thursday, and the new company, Bioceres Crop Solutions, began trading on the NYSE on Friday under the symbol BIOX

Cancel Save
Add Investment
Date Investors Type Amount
04/01/2016 Monsanto Growth Ventures Monsanto Growth Ventures , BAF Capital BAF Capital (2)
Post-money valuation of
(source)
Growth Equity
Delete
Click to add IPO information
Products
Save
Add Product
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font